Search Result "CML risk"
Current Treatment Concepts of CML
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 31-43
Author(s): A. A. Leitner, A. Hochhaus, M. C. Muller
On the Power of Additional and Complex Chromosomal Aberrations in CML
Journal: Current Genomics
Volume: 13 Issue: 6 Year: 2012 Page: 471-476
Author(s): Karin M. Greulich-Bode, Barbara Heinze
Towards Cure of CML: Why We Need to Know More About CML Stem Cells?
Journal: Current Stem Cell Research & Therapy
Volume: 4 Issue: 3 Year: 2009 Page: 224-236
Author(s): Jeroen J.W.M. Janssen, Gerrit J. Schuurhuis, Monique Terwijn, Gerrit J. Ossenkoppele
Advances in Immunotherapy of Chronic Myeloid Leukemia CML
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 7 Year: 2013 Page: 768-774
Author(s): Stefanie Andrea Erika Held, Annkristin Heine, Karin Tina Mayer, Mario Kapelle, Dominik Georg Friedrich Wolf, Peter Brossart
Stem Cell Transplantation for Chronic Myeloid Leukemia (CML): Current Indications and Perspectives
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 7 Year: 2013 Page: 775-778
Author(s): Andrea Bacigalupo
A Deeply Quiescent Subset of CML LSC depend on FAO yet Avoid DeleteriousROS by Suppressing Mitochondrial Complex I
Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-19
Author(s): Rafael J. Argüello
CYP1A1 and CYP2D6 Polymorphisms and Susceptibility to Chronic Myelocytic Leukaemia
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 9 Year: 2020 Page: 675-680
Author(s): Hadeil M.E. Idris,Hiba B. Khalil,Jeremy Mills,Abozer Y. Elderdery
Autophagy in Chronic Myeloid Leukaemia: Stem Cell Survival and Implication in Therapy
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 7 Year: 2013 Page: 724-734
Author(s): Gudmundur V. Helgason, Arunima Mukhopadhyay, Maria Karvela, Paolo Salomoni, Bruno Calabretta, Tessa L. Holyoake
The Association of rs2114358 in the miR-1206 Polymorphism to Chronic Myeloid Leukemia
Journal: MicroRNA
Volume: 8 Issue: 3 Year: 2019 Page: 248-252
Author(s): Fathelrahman Mahdi Hassan
Mechanisms of Resistance to Imatinib in CML Patients: A Paradigm for the Advantages and Pitfalls of Molecularly Targeted Therapy
Journal: Current Cancer Drug Targets
Volume: 6 Issue: 8 Year: 2006 Page: 645-657
Author(s): E. Ritchie, G. Nichols